Basel Medical Group Ltd Ordinary Shares (BMGL) vs Intelligent Bio Solutions Inc. (INBS)

A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and Intelligent Bio Solutions Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BMGL vs INBS

growth of $100 · dividends reinvested · last 2y
BMGL -94.1% (-75.6%/yr)INBS -91.6% (-71.0%/yr)INBS compounded faster over this window
050100Start $1002026$6$8
BMGL INBS

BMGL vs INBS: by the numbers

  • •INBS is the larger company ($5M vs $5M market cap).
  • •Both run net losses; BMGL's is the smaller (-106.78% vs -294.91% net margin).

Metrics side by side

Valuation

MetricBMGLINBS
P/S ratioN/A1.25
P/B ratio1.030.96

Profitability

MetricBMGLINBS
Gross margin77.68%48.63%
Operating margin-19.28%-305.03%
Net margin-106.78%-294.91%
ROE-248.66%-225.57%
ROIC-35.07%-179.58%

Growth (annualized)

MetricBMGLINBS
Revenue CAGR (5Y)N/A19.95%
Total return CAGR (5Y)N/A-80.26%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.